Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II adaptive proof-of-concept and dose-finding study of ASP3652 in CP/CPPS
2010-023775-25Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Prostatodynia (CP/CPPS) comparing ASP3652 with Placebo (2 arms). Primary endpoint: Change from baseline in NIH-CPSI total score at 12 weeks. Started Mar 2011; status: completed.
02
Drugs
asp3652
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on 2010-023775-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023775-25.